+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID03572465

Study of New Ultrasound and MRI Techniques to Diagnose Nonalcoholic Steatohepatitis and Liver Disease Severity

Led by Centre hospitalier de l'Université de Montréal (CHUM) · Updated on 2026-09-16

102

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Nonalcoholic fatty liver disease NAFLD is the most common liver disease in Western countries, often linked to type 2 diabetes and obesity. A more severe form, nonalcoholic steatohepatitis NASH, can progress to cirrhosis, liver cancer, or liver failure requiring transplantation. Diagnosing NASH currently requires a liver biopsy, an invasive procedure with risks and limitations, especially for asymptomatic patients. This study evaluates advanced quantitative ultrasound QUS techniques to diagnose NASH noninvasively and accurately. Participants will undergo new QUS imaging methods, including shear wave viscoelastography and sub-resolution cellular imaging, alongside magnetic resonance elastography MRE. These techniques aim to measure liver fat, inflammation, and fibrosis without the need for biopsy. The study includes both patients with suspected or known NAFLDNASH undergoing liver biopsy and non-obese volunteers without liver disease. Imaging tests will be performed close to the time of biopsy for comparison. During the study, participants will have imaging assessments using QUS and MRE within six weeks of liver biopsy or at study entry for volunteers. Researchers will analyze how well these imaging methods detect and grade liver disease compared to biopsy results. The study will monitor liver stiffness, fat content, and fibrosis stages, aiming to reduce reliance on invasive biopsies. Overall participation time varies but involves imaging and biopsy procedures within a defined timeframe.

CONDITIONS

Brief Title

Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis

Research Team

A

An Tang, MD, MSc

A

Assia Belblidia

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here